Free Trial
NASDAQ:AZTA

Azenta (AZTA) Stock Price, News & Analysis

Azenta logo
$27.61 +0.61 (+2.27%)
As of 09:47 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Azenta Stock (NASDAQ:AZTA)

Key Stats

Today's Range
$27.26
$27.97
50-Day Range
$25.03
$38.23
52-Week Range
$23.91
$63.58
Volume
1.11 million shs
Average Volume
689,567 shs
Market Capitalization
$1.26 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.67
Consensus Rating
Moderate Buy

Company Overview

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services. The Life Sciences Products segment offers automated cold storage solutions, consumables and instruments, controlled rate thawing devices, and temperature-controlled storage and transportation solutions. This segment also provides sample management solutions, such as consumable vials and tubes, polymerase chain reaction, plates, instruments for supporting workflows, and informatics. The Life Sciences Services segment provides genomic services, that includes gene sequencing and gene synthesis services; and sample repository solutions, such as on-site and off-site sample storage, cold chain logistics, sample transport and collection relocation, bio-processing solutions, disaster recovery and business continuity, and biospecimen procurement services, as well as project management and consulting services for genomic analysis and the management and care of biological samples used in pharmaceutical, biotech, healthcare, clinical, and academic research, and development sectors. It serves a range of life science customers, including pharmaceutical companies, biotechnology companies, biorepositories, and research institutes. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.

Azenta Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

AZTA MarketRank™: 

Azenta scored higher than 70% of companies evaluated by MarketBeat, and ranked 297th out of 920 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Azenta has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 2 buy ratings, 2 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Azenta has only been the subject of 2 research reports in the past 90 days.

  • Read more about Azenta's stock forecast and price target.
  • Earnings Growth

    Earnings for Azenta are expected to grow by 73.58% in the coming year, from $0.53 to $0.92 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Azenta is -9.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Azenta is -9.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Azenta has a P/B Ratio of 0.77. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Azenta's valuation and earnings.
  • Percentage of Shares Shorted

    10.94% of the float of Azenta has been sold short.
  • Short Interest Ratio / Days to Cover

    Azenta has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in Azenta has recently increased by 4.25%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Azenta does not currently pay a dividend.

  • Dividend Growth

    Azenta does not have a long track record of dividend growth.

  • Dividend Sustainability

    Based on earnings estimates, Azenta will have a dividend payout ratio of 10.87% next year. This indicates that Azenta will be able to sustain or increase its dividend.

  • Read more about Azenta's dividend.
  • Percentage of Shares Shorted

    10.94% of the float of Azenta has been sold short.
  • Short Interest Ratio / Days to Cover

    Azenta has a short interest ratio ("days to cover") of 6.
  • Change versus previous month

    Short interest in Azenta has recently increased by 4.25%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Azenta has a news sentiment score of 1.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 1.03 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 9 news articles for Azenta this week, compared to 5 articles on an average week.
  • Search Interest

    1 people have searched for AZTA on MarketBeat in the last 30 days.
  • MarketBeat Follows

    Only 1 people have added Azenta to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Azenta insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    10.62% of the stock of Azenta is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    99.08% of the stock of Azenta is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Azenta's insider trading history.
Receive AZTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Azenta and its competitors with MarketBeat's FREE daily newsletter.

AZTA Stock News Headlines

Big Oil’s big pivot
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle of the Utah's Black Desert. Why? Not for oil discovery. Or uranium or solar. Instead, what’s happening beneath this patch of sand is the discovery of a new kind of energy. Google, Buffett, and a even tech billionaires like Gates, Bezos, and Zuckerberg are grabbing a stake.
See More Headlines

AZTA Stock Analysis - Frequently Asked Questions

Azenta's stock was trading at $50.00 at the beginning of the year. Since then, AZTA shares have decreased by 44.6% and is now trading at $27.72.
View the best growth stocks for 2025 here
.

Azenta, Inc. (NASDAQ:AZTA) issued its earnings results on Wednesday, May, 7th. The company reported $0.05 earnings per share for the quarter, missing analysts' consensus estimates of $0.09 by $0.04. The business's revenue for the quarter was up 5.1% on a year-over-year basis.
Read the conference call transcript
.

Top institutional investors of Azenta include Vanguard Group Inc. (9.68%), Kayne Anderson Rudnick Investment Management LLC (4.67%), Conestoga Capital Advisors LLC (4.19%) and GW&K Investment Management LLC (2.82%). Insiders that own company stock include John Marotta, David C Gray, Matthew Mcmanus, Herman Cueto, Olga Pirogova, William L Cornog and Violetta Hughes.
View institutional ownership trends
.

Shares of AZTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Azenta investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), AUO (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/07/2025
Today
5/27/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
9/30/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Special industry machinery, not elsewhere classified
Sub-Industry
Machinery
Current Symbol
NASDAQ:AZTA
Employees
3,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$50.67
High Stock Price Target
$60.00
Low Stock Price Target
$40.00
Potential Upside/Downside
+82.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
52.30
P/E Growth
N/A
Net Income
-$164.17 million
Pretax Margin
-25.77%

Debt

Sales & Book Value

Annual Sales
$669.17 million
Cash Flow
$2.82 per share
Price / Cash Flow
9.84
Book Value
$36.16 per share
Price / Book
0.77

Miscellaneous

Free Float
40,843,000
Market Cap
$1.27 billion
Optionable
Optionable
Beta
1.64
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:AZTA) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners